Artwork

Innhold levert av Dr. Sue Pedersen. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Dr. Sue Pedersen eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!

Can semaglutide (Ozempic/Wegovy) cause loss of vision?

5:15
 
Del
 

Manage episode 427905218 series 3546736
Innhold levert av Dr. Sue Pedersen. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Dr. Sue Pedersen eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

A study just published in JAMA Opthalmology has been a big news topic this week, suggesting an association between semaglutide (Ozempic or Rybelsus for diabetes, Wegovy for weight loss) and nonarteritic anterior ischemic optic neuropathy (NAION), which can cause blindness. What’s the scoop?
Learn more: https://drsue.ca/2024/07/can-semaglutide-ozempic-wegovy-cause-loss-of-vision/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals.

  continue reading

51 episoder

Artwork
iconDel
 
Manage episode 427905218 series 3546736
Innhold levert av Dr. Sue Pedersen. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Dr. Sue Pedersen eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

A study just published in JAMA Opthalmology has been a big news topic this week, suggesting an association between semaglutide (Ozempic or Rybelsus for diabetes, Wegovy for weight loss) and nonarteritic anterior ischemic optic neuropathy (NAION), which can cause blindness. What’s the scoop?
Learn more: https://drsue.ca/2024/07/can-semaglutide-ozempic-wegovy-cause-loss-of-vision/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals.

  continue reading

51 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

 

Hurtigreferanseguide

Copyright 2024 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett